Replies to post #196515 on Amarin Corp Plc (AMRN)

[Biobillionair]

Sam

Don't they have 4 business days to release material information to the market?

JT was clear yesterday, Amarin has no idea what the FDA intends to do regarding Ad Com. Amarin is planning for an Ad Com.

I highly doubt FDA can schedule an Ad Com without shining a spot light on ANCHOR; remember right or wrong the rescindment of ANCHOR has led to a considerable amount of deaths. The FDA isn’t going to admit involvement in mortality; especially since professional groups recommend treatment of high Trigs in type 2 diabetics at the time of rescindment.

BB

[marzan]

Samy, JT said yesterday as of yesterday he didn't receive any second letter from FDA. As you know he gave the best presentation yesterday. He said V is the best beating any other drug in the market efficacy wise and cost wise including statins even though he kept saying V is not a competition drug but going to be volume play. He said everything that one can say the best.

[oneragman]

Sam, at this point IMO the only way they have an AdCom is if during the review, they unexpectedly find something in the data that causes concerns. That can happen well into the review giving the FDA the opportunity to change course. I would say the odds of that happening are .1%.

[HDGabor]

S-

Any thoughts about the above?

1.) They aren't who will sit 4 business days to release material information to the market
2.) will be 99,99% sure by June 17

Best,
G